You may be surprised to learn that the medication sildenafil—better known by its brand name Viagra—has other medical purposes aside from treating male erectile dysfunction. It can also be used to treat lung diseases that ...
Sep 29, 2022
0
9
A device known as the BASHIR Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, ...
Sep 19, 2022
0
5
Matters of the heart can sometimes be resolved from within. Pulmonary arterial hypertension, or PAH, caused by a thickening of the arterial walls and narrowing of the lumen can be fatal if left untreated. The use of vasodilators ...
Sep 7, 2022
0
5
Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines ...
Aug 26, 2022
0
5
Researchers at the National Institutes of Health have found that a novel blood test can be used to easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability. PAH is ...
Aug 25, 2022
0
36
Clinical researchers at Hannover Medical School (MHH) have succeeded for the first time in stopping the usually fatal course of pulmonary hypertension thanks to a novel therapeutic approach. A three-year-old girl suffering ...
Jun 10, 2022
0
168
Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the lungs, in which blood vessels are narrowed, blocked or destroyed, causing the heart to work harder and, in time, result in cardiac weakness and ...
May 6, 2022
0
106
Depression can complicate and slow recovery from a heart attack, not to mention the toll it can take on one's mental outlook, relationships and joy of life. In addition, new research finds that people who had depression following ...
Mar 23, 2022
0
5
A genetic disorder in PRDM6 causes patent ductus arteriosus (PDA), a congenital heart defect common in premature infants—suggesting a potential target for the treatment of congenital heart diseases.
Feb 14, 2022
0
112
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
